Skip to main content

Advertisement

Springer Nature Link
Log in

Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Long-term survival of patients with systemic lupus erythematosus (SLE) improved worldwide; thus, prevention of cumulative organ damage became a major goal in disease management. The aim of our study was to investigate the chronic organ damages and their influence on disease outcome in SLE. We evaluated clinical conditions, laboratory findings and medications of 357 consecutive SLE patients and assessed their impact on Systemic Lupus Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) and disease outcome. We detected one or more SDI scores in 77.87% of patients. Patients with disease duration of more than 10 years and subjects diagnosed at age above 40 had significantly higher SDI values. The most frequent damages were valvulopathies, cognitive dysfunction, angina pectoris and venous thrombosis. Higher cumulative glucocorticoid dose increased SDI, while chloroquin treatment was favourable for patients. Male gender, elevated SDI scores and higher cumulative doses of glucocorticoids increased mortality risk. Our data confirmed that disease duration, age at diagnosis and chronic high-dose glucocorticoid therapy have significant effects on the development of chronic organ damage. Higher SDI score is characterized with worse survival ratios. The most common chronic organ damages affected the cardiovascular or neuropsychiatric system. As long-term survival in SLE improves, it becomes increasingly important to identify the determinants of chronic organ damage. Most of the chronic organ damage occurs in the cardiovascular and the neuropsychiatric systems; thus, regular follow-up, screening and adequate therapy are essential for the best clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kiss E, Regéczy N, Szegedi G (1999) Systemic lupus erythematosus survival in Hungary. Results from a single center. Clin Exp Rheumatol 17:1–7

    Google Scholar 

  2. Tarr T, Kiss E, Szegedi G, Zeher M (2011) Sort and long term survival and causes of death in patient with systemic lupus erythematosus [in Hungarian]. LAM 21:185–191

    Google Scholar 

  3. Rabbani MA, Habib HB, Islam M, Ahmad B, Majid S, Saeed W, Shah SM, Ahmad A (2009) Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus 18:848–855

    Article  PubMed  Google Scholar 

  4. Wadee S, Tikly M, Hopley M (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) 46:1487–1491

    Article  CAS  Google Scholar 

  5. Chambers SA, Allen E, Rahman A, Isenberg D (2009) Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford) 48:673–675

    Article  Google Scholar 

  6. Gonzalez LA, Pons-Estel GJ, Zhang JS, McGwin G Jr, Roseman J, Reveille JD, Vilá LM, Alarcón GS (2009) Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII). Lupus 18:184–186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gladman D, Ginzler E, Goldsmith C, Bacon P, Fortin P, Ginzler E (1992) Systemic Lupus International Collaborating Clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol 19:1820–1821

    CAS  PubMed  Google Scholar 

  8. Sutton EJ, Davidson JE, Bruce IN (2013) The Systemic Lupus International Collaborating Clinics (SLICC) damage index: a systematic literature review. Semin Arthritis Rheum 43:352–361

    Article  PubMed  Google Scholar 

  9. Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A, Ugalde J, Aguirre C (2004) Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus. Lupus 13:900–905

    Article  CAS  PubMed  Google Scholar 

  10. Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Shulman LE, Wallace SL (1971) Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 21:643–648

    Google Scholar 

  11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  CAS  PubMed  Google Scholar 

  12. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 140:1725

    Article  Google Scholar 

  13. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification for definite antiphospholipid syndrome. Arthritis Rheum 42:1309–1311

    Article  CAS  PubMed  Google Scholar 

  14. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  CAS  PubMed  Google Scholar 

  15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 35:630–640

    Article  CAS  PubMed  Google Scholar 

  16. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291

    PubMed  Google Scholar 

  17. Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, gender, and disease duration in systemic lupus erythematosus. Rheumatology 42:276–279

    Article  CAS  PubMed  Google Scholar 

  18. del Toro ME, Capote AC, Hechavarría H, Paneque RJ, Kokuina E (2010) Damage in Cuban patients with systemic lupus erythematosus. Relation with disease features. Rheumatol Clin 6:11–15

    Google Scholar 

  19. Andrade RM, Alarcon GS, Fernandez M, Apte M, Vila LM, Reveille JD (2007) Accelerated damage accrual among men with systemic lupus erythematosus. Arthritis Rheum 56:622–630

    Article  PubMed  Google Scholar 

  20. Sung YK, Hur NW, Sinskey JL, Park D, Bae SC (2007) Assessment of damage in Korean patients with systemic lupus erythematosus. J Rheumatol 34:987–991

    PubMed  Google Scholar 

  21. Rivest C, Lew RA, Welsing PM, Sangha O, Wright EA, Roberts WN, Liang MH, Karlson EW (2000) Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 27:680–684

    CAS  PubMed  Google Scholar 

  22. Cassano G, Roverano S, Paira S, Bellomio V, Lucero E, Berman A, Spindler A, Trobo R, Somma LF, Graf C, Barrionuevo A, Papasidero S, Rillo O (2007) Accrual of organ damage over time in Argentine patients with systemic lupus erythematosus: a multi-centre study. Clin Rheumatol 26:2017–2022

    Article  PubMed  Google Scholar 

  23. Gladman DD, Urowitz MB, Rahman P, Ibañez D, Tam LS (2003) Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 30:1955–1959

    PubMed  Google Scholar 

  24. Becker-Merok A, Nossent HC (2006) Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. J Rheumatol 33:1570–7157

    PubMed  Google Scholar 

  25. Lopez R, Davidson JE, Beeby MD, Egger PJ, Isenberg DA (2012) Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort. Rheumatology 51:491–498

    Article  PubMed  Google Scholar 

  26. Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA (2004) Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus—a 5-yr prospective study. Rheumatology 43:1039–1044

    Article  CAS  PubMed  Google Scholar 

  27. Maddison P, Farewell V, Isenberg D, Aranow C, Bae SC, Barr S, Buyon J, Fortin P, Ginzler E, Gladman D, Hanly J, Manzi S, Nived O, Petri M, Ramsey-Goldman R, Sturfelt G (2002) The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29:913–917

    PubMed  Google Scholar 

  28. Morgan TA, Watson L, McCann LJ, Beresford MW (2013) Children and adolescents with SLE: not just little adults. Lupus 22:1309–1319

    Article  CAS  PubMed  Google Scholar 

  29. Feng X, Zou Y, Pan W, Wang X, Wu M, Zhang M, Tao J, Zhang Y, Tan K, Li J, Chen Z, Ding X, Qian X, Da Z, Wang M, Sun L (2014) Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus. Lupus 23:327–334

    Article  CAS  PubMed  Google Scholar 

  30. Thamer A, Hernán MA, Zhang Y, Cotter D, Petri M (2009) Relationship between prednisone, lupus activity and permanent organ damage. J Rheumatol 36:560–564

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, Beristain-Manterola R, Maeno N, Takei S, Gerloni V, Spencer CH, Pratsidou-Gertsi P, Ruperto N, Pistorio A, Martini A (2003) Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 49:501–507

    Article  PubMed  Google Scholar 

  32. Pons-Estel GJ, Alarcón GS, González LA, Zhang J, Vilá LM, Reveille JD, McGwin G Jr, Lumina Study Group (2010) Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort. Arthritis Care Res (Hoboken) 62:393–400

    Article  Google Scholar 

  33. Akhavan PS, Su J, Lou W, Gladman DD, Urowitz MB, Fortin PR (2013) The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus. J Rheumatol 40:831–841

    Article  CAS  PubMed  Google Scholar 

  34. Molad Y, Gorshtein A, Wysenbeek AJ, Guedj D, Majadla R, Weinberger A, Amit-Vazina M (2002) Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort. Lupus 11:356–361

    Article  CAS  PubMed  Google Scholar 

  35. Mok CC, Ho CT, Wong RW, Lau CS (2003) Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 30:1513–1519

    PubMed  Google Scholar 

  36. Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G (2016) The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort. Lupus 25:719–726

    Article  CAS  PubMed  Google Scholar 

  37. Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, Hughes G (2016) Systemic lupus erythematosus. Nat Rev Dis Primers 2:16039. doi:10.1038/nrdp.2016.39

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Móricz Zs. str. 22, Debrecen, 4032, Hungary

    Tünde Tarr, Gábor Papp, Nikolett Nagy, Edina Cserép & Margit Zeher

Authors
  1. Tünde Tarr
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Gábor Papp
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Nikolett Nagy
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Edina Cserép
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Margit Zeher
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Margit Zeher.

Ethics declarations

All experiments carried out in the study were in compliance with the Declaration of Helsinki.

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tarr, T., Papp, G., Nagy, N. et al. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus. Clin Rheumatol 36, 327–333 (2017). https://doi.org/10.1007/s10067-016-3492-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3492-6

Keywords